Sep 14, 2026 07:30AM
Sep 14, 2026 07:30AM
Sep 8, 2026 07:30AM
Sep 8, 2026 07:30AM
May 14, 2026 07:30AM
May 13, 2026 07:30AM
May 13, 2026 07:30AM BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 12, 2026 07:30AM
May 12, 2026 07:30AM
May 7, 2026 07:30AM
May 7, 2026 07:30AM
May 6, 2026 07:30AM
Jan 27, 2026 07:30AM
Jan 27, 2026 07:30AM BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Nov 25, 2025 07:30AM
Nov 25, 2025 07:30AM
Oct 22, 2025 07:30AM
Oct 22, 2025 07:30AM
Oct 21, 2025 07:50AM
Oct 21, 2025 07:50AM
Oct 20, 2025 07:31AM BriaCell presents Phase 3 biomarker data at ESMO conference
Oct 20, 2025 07:30AM
Jul 31, 2025 07:30AM
Jul 31, 2025 07:30AM
Jul 2, 2025 07:30AM
Jun 24, 2025 07:30AM
May 23, 2025 07:42AM
May 23, 2025 07:30AM BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025
Apr 22, 2025 07:30AM
Mar 20, 2025 08:00AM
Dec 2, 2024 07:50AM
Dec 2, 2024 07:50AM
Oct 15, 2024 07:51AM
Oct 15, 2024 07:50AM
Sep 10, 2024 07:51AM BriaCell Therapeutics (BCTX) Announces Positive Pre-IND Meeting with FDA for Bria-PROS+ for Prostate Cancer
Sep 10, 2024 07:50AM
Jun 27, 2023 08:05AM
May 15, 2023 08:01AM
May 15, 2023 08:00AM
Feb 23, 2023 08:03AM
Feb 23, 2023 08:00AM
Jan 24, 2023 09:07AM BriaCell CEO Letter to Shareholders
Jan 18, 2023 08:48AM
Jan 18, 2023 08:47AM
Jan 10, 2023 09:00AM
Dec 8, 2022 09:25AM
Nov 10, 2022 09:01AM
Nov 10, 2022 09:00AM
Oct 21, 2022 09:00AM BriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation Progressing
Jul 5, 2022 09:00AM

334,870 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All